Responses
Oral Presentations
Progress in managment of SpA
OP0023 Four-year imaging outcomes in axial spondyloarthritis patients treated with certolizumab pegol, including patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.